Abstract
In Africa, about 33 000 cases of obstetric fistula occur each year. Women with fistula experience debilitating incontinence of urine and/or faeces and are often socially ostracized. Worldwide, Uganda ranks third among countries with the highest burden of obstetric fistula. Obstetric fistula repair competes for scarce resources with other healthcare interventions in resource-limited settings, even though it is surgically efficacious. There is limited documentation of its cost-effectiveness in the most affected settings. We therefore sought to assess the cost-effectiveness of surgical intervention for obstetric fistula in Uganda so as to provide appropriate data for policy-makers to prioritize fistula repair and reduce women’s suffering in similarly burdened countries. We built a decision-analytic model from the perspective of Uganda’s National Health System to estimate the cost-effectiveness of vesico-vaginal and recto-vaginal fistula surgery vs a competing strategy of no surgery for Ugandan women with fistula. Long-term disability outcomes were assessed based on a lifetime Markov state-transition cohort and effectiveness of surgery. Surgical costs were estimated by micro-costing local Ugandan health resources. Disability weights associated with vesico-vaginal, recto-vaginal fistula and mortality rates among the general population in Uganda were based on published sources. The cost of providing fistula repair surgery in Uganda was estimated at $378 per procedure. For a hypothetical 20-year-old woman, surgery was estimated to decrease the lifetime disability burden from 8.53 DALYs to 1.51 DALYs, yielding a cost per DALY averted of $54. The results were robust to variations in model inputs in one-way and probabilistic sensitivity analyses. Surgery for obstetric fistula appears highly cost-effective in Uganda. In similar low-income countries, governments and non-governmental organizations need to prioritize training and strengthening surgical capacity to increase access to fistula surgical care, which would be an important step towards achieving universal health coverage.
Keywords: Health policy, cost-effectiveness analysis, maternal morbidity and mortality, obstetric fistula in Uganda, low-income countries, health financing, cost analysis
Key Messages
The United Nations 2030 agenda for sustainable development embraces Good health as a precondition for, an outcome and measure of, sustainable development. The drivers of good health are interdependent, and as in obstetric fistula, socio-economic factors, health systems, health infrastructure, personnel and health financing are essential components of Universal Health Coverage that need to be addressed.
In addition, the third Disease Control Priorities (DCP3) reports that once women develop fistulas, transportation to a medical facility is extremely difficult because of the cost of transportation and also because of the inadequate hygiene and leaking that women with fistulas exhibit. A 2001 United Nations Population Fund (UNFPA) survey of fistula patients in Tanzania reports that some women travel as far as 500 kilometres to reach the nearest fistula centre (UNFPA 2001). The survey notes that of 32 fistula centres, only 3 provide free surgery.
The prevention of fistula requires significant social and economic attention. Investing in medical facilities that are able to provide adequate prenatal care as well as healthy deliveries needs to be a priority (DCP3). Prenatal care, with early identification of at-risk pregnancies coupled with early referral to delivery centres capable of operative delivery, is essential for prevention. The cost of prenatal care varies by country, as well as by government-provided insurance plan, but all costs for these preventive strategies are significantly lower than the cost of later treatment (DCP3).
Achieving the 2030 agenda of sustainable development worldwide will require significant advances in Maternal and Child Health. This will entail a global strategy towards strengthening of the health systems to provide this cost-effective fistula surgery, and address the gaps leading to prolonged obstructed labour in low- and middle-income countries. Our study provides data on the cost and cost-effectiveness of obstetric fistula repair from Uganda, a low-income country in Sub-Saharan Africa. Here, we provide data that might convince policy-makers to prioritize this type of surgery and therefore reduce the burden of fistula.
This is the first publication on cost-effectiveness of obstetric fistula repair in the region; where we estimated the cost and cost-effectiveness of surgical repair for obstetric fistula. Our model found obstetric fistula surgical repair to be the optimal strategy for management of this condition. Surgery for obstetric fistula is highly cost-effective in Uganda. Our finding is consistent with a previous modelled analysis of surgically avertable obstetric conditions in lower- and middle-income countries. Increasing access to quality and highly effective obstetric and fistula surgery could improve health outcomes for many affected women in resource-limited settings. Our study therefore provides data for policy makers to prioritize implementation of this highly cost-effective procedure in developing countries. This will be a great step towards achieving the World Health Assembly resolution on ‘Strengthening emergency and essential surgical care and anaesthesia as a component of Universal Health Coverage’.
Introduction
Globally, every day, an estimated 830 women die from complications arising during pregnancy or childbirth; with 99% of deaths occurring in developing countries. However, for every maternal death, 30–50% of women who survive suffer disabling or humiliating injuries including obstetric fistula (World Health Organization, 2015; You et al., 2015). In Sub-Saharan Africa alone, 33 000 new cases of obstetric fistula occur annually (UNFPA, 2005) driven by prolonged obstructed labour, poverty, inaccessible health services, poor utilization of health services, poor referral systems and low quality of health services, including poorly-managed caesarean sections (Hancock, 2005; UNFPA, 2005; Kelly and Winter, 2007; Barageine et al., 2014). In Uganda, the burden of obstetric fistula remains unacceptably high at 2% of women of reproductive age, 15–49 years (UBOS, 2012). Obstetric fistula may be found in older women, often having lived for decades with this condition. Currently, an estimated 200 000 Ugandan women have obstetric fistula with up to 1900 new cases occurring each year (MOH, 2011).
Usually, obstetric fistula is a complication of prolonged obstructed labour, caused by cephalo-pelvic disproportion and poor obstetric care. Specifically, obstetric fistula results from necrosis of the anterior and sometimes posterior vaginal wall, bladder, urethra and rectum, after prolonged compression of these tissues by the foetal head and the maternal pubis during labour. Between the 4th and 14th day post-partum, after the necrotic tissue sloughs off, incontinence appears. Risk factors for obstetric fistula include malnutrition or stunting, repeated infections, large babies (weight 3.5 kg or higher), insufficient access to emergency obstetric care, preference delivery at home with Traditional Birth Attendants, short stature (<150 cm tall) and poorly managed caesarean sections at health facilities (Tebeu et al., 2012; Barageine et al., 2014). Adolescents are at increased risk for obstetric fistula due to physical immaturity and a less developed pelvis (Tebeu et al., 2012).
Obstetric fistula occurs almost exclusively in women living in low-income settings. The social impact of urinary incontinence is isolation, social deprivation and inability to engage in household chores and productive socioeconomic activities to support their families (Barageine et al., 2015; Mselle and Kohi, 2015). Compounding economic losses, incontinence leads to soiling of personal effects and generates odours that strain interpersonal relationships and obstetric fistula has been shown to significantly reduce quality of life (Barageine et al., 2015). Medical and gynaecological complications may include acquisition of infections, depression and anxiety (Hilton and Ward, 1998; Browning et al., 2007; Holme et al., 2007). Obstetric fistula results in a high burden of disease (as measured in disability adjusted life years or DALYs) because the condition occurs in young women. Surgical repair of obstetric fistula is often complex and may require long hospital stays, exacting a toll on the health system (Barageine et al., 2015; Mselle and Kohi, 2015).
Obstetric fistula is prevented by access to skilled care during delivery, closely monitoring progress during labour, and by providing timely caesarean sections when indicated (Higashi et al., 2015). However, low- and middle-income countries lack sufficient surgeons and resources to treat patients with obstetric fistula. The current total capacity for fistula repair in Sub-Saharan Africa is estimated to be around 10 000 women per year (Vangeenderhuysen et al., 2001) but 2 000 000–4 000 000 African women are estimated to have an unrepaired vesico-vaginal fistula (Vangeenderhuysen et al., 2001; Wall, 2006).
While the current estimates of unmet need for fistula surgical repair in low-income countries are not well documented, it was estimated to be as high as 99% in 2008 (Ahmed et al., 2007), and the morbidity and mortality posed by obstructed labour remains unacceptably high in contrast to the numbers seen in the high-income countries (Lozano et al., 2012; Adler et al., 2013).
Obstetric fistula may be managed conservatively using a Foley’s catheter or surgically for complicated or longstanding fistulas (Waaldijk, 2004). The Foley’s urethral catheter (which is used for fresh small genital fistulas, <2 cm) permits continuous bladder drainage promotes healing of the fistula by preventing distension of the urinary bladder (Waaldijk, 2004; Arrowsmith et al., 2010). When Foley’s catheters fail, or when fistulae fail to close, surgical repair is the recommended treatment. Following surgical repair, patients remain in hospital for 14 days for strict catheter care (Creanga Andrerea et al., 2008; FIGO and UNFPA, 2011). The success rate for surgical repair can exceed 92% if the surgeon has the requisite expertise and the fistula is not a recurrence (Waaldijk, 1995; Raassen et al., 2008; Brian and Browning, 2009; Hancock, 2009; Kayondo et al., 2011).
In Uganda, patients undergoing fistula surgery are treated following WHO guidelines and national policies are available (Lewis and De Bernis, 2006; MOH, 2011). However, there is limited access to fistula care because few surgeons in the country are able to carry out fistula repairs and care is often delivered via periodic surgical camps organized by local and expatriate surgeons (MOH, 2007; 2011). The United Nations Population Fund estimated that a fistula surgical repair would cost $75–120 at a Ugandan hospital in Kamuli, but how this calculation was made was not explained and this figure is likely outdated (UNFPA and MOH, 2004). To date, the cost and effectiveness of fistula repair in low-income settings like Uganda has not been systematically evaluated.
Here, findings are presented from a simulation model of the cost-effectiveness of obstetric fistula repair at Mulago, a centre of excellence for fistula repair in Uganda. Results of this analysis could assist policy-makers in determining whether surgical repair of fistula should be prioritized. These results could guide budgetary decisions about whether to invest additional resources into the training of healthcare personnel to prevent, identify and treat obstetric fistula in Uganda and other low-income settings.
Methods
The study was conducted in two phases. In the first phase, the average cost of vesico-vaginal and recto-vaginal fistula repair from the provider’s perspective was estimated in the target population. Consistent with published methodological recommendations (Hendriks et al., 2014), this cost analysis utilized a bottom-up micro-costing approach, where healthcare resources necessary for performing fistula surgery were identified through expert interviews. Thereafter, each resource was assigned a cost on the basis of publicly available local price lists. The average cost of fistula surgery was defined as the sum of all individual cost components. The study excluded overhead costs not directly related to the surgical procedure, including those associated with the hospital building or general healthcare infrastructure, and indirect costs such as travel time or work loss for the individual patient as a consequence of the surgery.
In the second phase, a decision-analytic model was developed to estimate the cost-effectiveness of fistula surgery in a cohort of Ugandan women at an average age of 20 years from the perspective of the national health system (Figure 1). The model compared a strategy of fistula surgery to a strategy of no surgery. Long-term disability outcomes were evaluated using a lifetime Markov state-transition cohort with annual cycle length. The effectiveness of surgery, disability weight associated with vesico-vaginal fistula and mortality rate among women in the general population in Uganda were obtained from published sources (Salomon et al., 2012). The cost of fistula repair surgery was estimated from the first phase of the project. All future costs and benefits were discounted at 3% per year. Calculations were performed using TreeAge Pro 2017 (Treeage Software, Inc., Williamstown, MA, USA)
Figure 1.
Model structure.
Settings
The analysis was conducted at the Centre for Fistula Care in Mulago National Referral Hospital in Kampala (Mulago) and at Kitovu Regional Referral Hospital in Kitovu, Uganda. Surgeons at Mulago perform approximately 240–360 surgical fistula repairs per year, as compared with about 1000 repairs per year performed at Kitovu. In one-on-one interviews, urogenital gynaecologists who perform fistula repair surgeries and supporting nurses provided information on the average time and human resources required for a typical surgery. Respondents were asked to list all other healthcare resources (surgical instruments, pharmaceuticals and number of hospital days for recuperation) that are generally associated with fistula repair surgery. (Tables 1–3; Cost inputs for fistula surgery: To obtain the total costs of the Fistula repair the costs of the personnel and laboratory investigations (Table 1), anaesthesia supplies and equipment (Table 2) and surgery supplies and equipment (Table 3). The average cost per surgery on combining all the cost estimations, including 28 day admission costs for the patient was $378.04 USD.) Monthly salary data were self-reported by the individual respondents and converted to an average cost per surgery, assuming that the surgeons and support staff would participate in 24 surgeries per month. The cost per hospital day was assessed through interviews with hospital administrators. The costs of pharmaceuticals, surgical equipment and other healthcare resources associated with pre- and post-surgery care were obtained from the Ugandan Joint Medical Stores catalogue of November 2016 (JMS Uganda, 2016). Local currency was converted at an exchange rate of 3400 Ugandan Shillings per 1 US dollar (2016).
Table 1.
The cost personnel and laboratory investigations
| Item | Details | Cost in USD | Number of surgeries per month | Cost per surgery in USD | Useful life/unit size |
|---|---|---|---|---|---|
| A. Personnela | |||||
| Anaesthesiologist | 01 | 529.41 | 40 | 13.24 | Monthly salary: 529.41 |
| Nurse | 01 | 205.88 | 24 | 4.90 | Monthly salary: 205.88 |
| Senior house officer | 01 | 205.88 | 100 | 2.51 | Monthly salary: 205.88 |
| Urogynaecological surgeon | 01 | 529.41 | 24 | 22.06 | Monthly salary: 529.41 |
| B. Lab investigations | CBC (HB) | 4.41 | 4.41 | ||
| C. Patient accommodation | 28 days (14 days before and after repair) | 82.35 | 82.35 | 28 days |
Personnel salaries as per Ministry of Health Uganda Structure.
Table 2.
The costs for the anaesthesia supplies and equipment
| Item | Details | Cost in USD | Number of surgeries per month | Cost per surgery in USD | Useful life/unit size |
|---|---|---|---|---|---|
| Anaesthesia supplies | |||||
| Anaesthesia machine | Anaesthesia machine | 25 000.00 | 17.36 | 5 years if well serviced | |
| Suction machine | Suction machine | 779.41 | 1.35 | 2 years if well serviced | |
| Anaesthesia machine exhaust chamber maintenance and gauges for oxygen replacement | 132.35 | 0.46 | Once a year | ||
| Suction machine maintenance: replacing white filters | 10.294 | 0.86 | Every 2 weeks | ||
| Spinal needles | Spinal needles (orange gauge 22, black) (1 or 2) | 5.88 | 5.88 | Single use per surgery | |
| 90% of the time spinal anaesthesia | Bupivacaine (1 bottle) (0.5% 20 ml vial) | 3.71 | 3.34 | Single use per surgery | |
| 10% of cases general anaesthesia | Isoflurane (1 bottle) | 42.35 | 4.23 | ||
| Ketamine (1 bottle) | 1.04 | 1.04 | |||
| Endo tracheal tubes 6.5/7.0 | 0.82 | 0.82 | |||
| Laryngoscope | 119 | 0.08 | 5 years | ||
| Suction catheters | 0.22 | 0.22 | Single use per surgery | ||
| IV Fluids—normal saline | Normal saline (6 in number) | 2.52 | 2.52 | Single use per surgery | |
| Cannula gauge 16/18 (2 of them) | 2.54 | 2.54 | Single use per surgery | ||
| Giving sets (2 o them) | 10.75 | 10.75 | |||
| Monitors | BP, O2, pulse rate monitor | 882.35 | 24 | 0.61 | Lifetime of the machine is 5 years |
| Surgeons cocktail | Adrenaline | 4.41 | 4.41 | Single use per surgery | |
| Lignocaine (2%), 20 ml vial | 8.55 | 8.55 | Single use per surgery | ||
| Antibiotics | – | – | |||
| 1. 160 mg gentamycin IV | Once | 2.35 | 2.35 | Single use per surgery | |
| 2. 1G IV ceftriaxone | Once | 5.88 | 5.88 | Always used | |
| Analgesics | – | – | |||
| 1. Pethidine 50 mg (IM) | 3 doses | 5.20 | 5.20 | ||
| 2. Diclofenac I/V I/M 75 mg (25 mg/ml 3 ml ampoule) | 3 doses | 14.34 | 14.34 | ||
| 3.Tramadol 100 mg (iv) | 3 doses | 3.74 | 3.74 | May or may not be used |
Table 3.
The inputs for the costs of the Surgery supplies and equipment
| Item | Details | Cost in USD | Number of surgeries per month | Cost per surgery in USD | Useful life/unit size |
|---|---|---|---|---|---|
| Surgery supplies and equipment | |||||
| Gloves | – | – | |||
| – Sterile gloves size 7, 7.5 | 1 box | 12.35 | 1.5 | Each box has 50 pairs. Considering 6 pairs of gloves used per surgery. | |
| – Un-sterile box | 1 box | 0.43 | 0.01 | ||
| – Heavy duty gloves for cleaning | 1 pair ×5 | 73.55 | 1.02 | 3 months | |
| – Jik (cleaning) | 1 bottle | 4.41 | 4.41 | Single use per surgery | |
| – Soap (cleaning) | 1 litre | 13.24 | 13.24 | ||
| Sutures | – | – | |||
| Vycril 2.0 | 1 | 0.74 | 0.74 | Single use per surgery | |
| Vycril 3.0 | 2 | 0.74 | 0.74 | Single use per surgery | |
| Vycril 1.0 | 1 | 1.91 | 1.91 | Single use per surgery | |
| Linen 1/0 | 1 | 1.91 | 1.91 | Single use per surgery | |
| PDS suture | 1 | 1.03 | 1.03 | Single use per surgery | |
| Nylon | 1 | 1.47 | 1.47 | Single use per surgery | |
| Urinary catheters | – | – | |||
| 1. Urethral catheter size 14/16 | One catheter | 8.40 | 8.40 | Single use per surgery | |
| 2. Ureteric catheter | 29.41 | 0.03 | 3 years | ||
| 3. Dye test | Bottle of the dye | 8.82 | 8.82 | Single use per surgery | |
| Linen in theatre | – | – | |||
| 1. Towels (covers instrument trolley, patients bed) | 1 metre | 10.94 | 10.94 | 3 months | |
| 2. Abdominal sheets | 1 metre | 10.94 | 10.94 | 3 months | |
| 3. Legging clothes (covers the thighs) | 1 metre | 10.94 | 10.94 | 3 months | |
| 4. Theatre scrubs | 2 pieces | 15.28 | 0.64 | Assumes that a pair of scrubs will be used for 24 surgeries | |
| Skin preps | Antiseptic povidone | 6.50 | 6.50 | Single use per surgery | |
| Plaster | Plaster (medium roll) | 7.73 | 0.77 | It can be used for up to 10 patients | |
| Others | Cotton | 4.41 | 0.88 | ||
| Syringes 2, 5, 10 ml | 0.44 | 1.76 | Use up to 4 needles | ||
| Gauze | 9.07 | 9.07 | |||
| Surgical blade | 5.51 | 5.51 | |||
| Masks | 6 pieces (disposable) | 13.25 | 13.25 | Single use per surgery | |
| Gowns (cotton large reusable) | 2 pieces | 17.29 | 17.29 | 3 months | |
| Head caps (cotton reusable) | 4 pieces | 2.12 | 2.12 | 3 months | |
| Re-usable surgical set for VVF repair | – | – | |||
| Auvard | 55.62 | 0.10 | Wears out after 2 years | ||
| Needle holders | 10.09 | 0.02 | Wears out after 2 years | ||
| Scissors | 6.46 | 0.01 | Wears out after 2 years | ||
| Tissue forceps | 5.80 | 0.01 | Wears out after 2 years | ||
| Sponge holding forceps | 9.60 | 0.02 | Wears out after 2 years | ||
| Artery forceps | 6.70 | 0.01 | Wears out after 2 years | ||
| Sims speculum | 5.21 | 0.01 | Wears out after 2 years | ||
| Receiver | 6.47 | 0.01 | Wears out after 2 years | ||
| Uterine sound | 5.14 | 0.01 | Wears out after 2 years | ||
| Metallic catheter | 84.28 | 0.15 | Wears out after 2 years | ||
| Probe | 1.37 | 0.002 | Wears out after 2 years | ||
| Varicellum | 5.15 | 0.01 | Wears out after 2 years | ||
| Dissecting forceps (toothed) | 6.18 | 0.01 | Wears out after 2 years | ||
| Dissecting forceps (non toothed) | 3.36 | 0.01 | Wears out after 2 years | ||
| Towel clips | 5.35 | 0.01 | Wears out after 2 years | ||
| Bakock | 30.25 | 0.05 | Wears out after 2 years | ||
| Two gallipots | 6.47 | 0.01 | 2 years | ||
| Sterilizer | 830 | 0.57 | 5 years if well serviced | ||
| Sterilizer maintenance (valves, gaskets, relays) | 161.76 | 0.37 | Replaced 1.5 years | ||
| Monthly cleaning of air exhaust tube Small diameter wire 6 months | Done once every month for 30–40 min | 20.59 | 0.86 | ||
| Bi-weekly cleaning of control valve acetone 1 month | Done every 2 weeks for 20 min | 147.06 | 12.26 | Twice a month | |
| Water buckets | __3 buckets | 13.24 | 13.24 | ||
| Water 80 L required per day | Cleaning the theatre | 0.29 | 0.29 | ||
| Heavy duty gloves 5 required 3 months (for cleaning the theatre) | One pair | 5.88 | 5.88 | 3 months |
Model inputs
Baseline proportions of 78.8% for vesico-vaginal fistula and 21.2% for recto-vaginal fistula were obtained from an Ethiopian study of 716 women presenting for fistula surgery (Kelly, 1992). In that cohort, both fistula types were observed to co-occur in 16.9% of cases, but the model made the simplifying assumption that co-occurring vesico-vaginal and recto-vaginal fistula could be repaired in a single surgery. Without surgical intervention, it was assumed that the presence of fistula would carry a disability weight of 0.338 for vesico-vaginal and 0.492 for recto-vaginal fistula, and that this disability would persist over the remaining lifetime of the patient (Salomon et al., 2012). When both fistula types co-occurred, the higher disability weight was assumed. Obstetric fistula was not assumed to increase the risk of mortality in the control arm; that is, the burden of disease was driven entirely by the impact of disability.
Similarly, expected surgical outcomes in the intervention arm were informed by results of the Ethiopian study, .where successful fistula repair was accomplished in 84.6% of patients, surgery failed in 6.3% and an outcome of stress incontinence persisted in 9.1% (Kelly, 1992). For a successful surgical outcome, a disability weight of zero was applied in the model. Persistent stress incontinence carried a disability weight of 0.142 (Salomon et al., 2012). Unsuccessful fistula repair was associated with disability weights matching those of patients in the control arm of the model. The possibility of repeat surgery in unsuccessful cases was excluded from the model. Annual mortality rate of Ugandan women in the general population was obtained from publicly available life tables (WHO, 2011a). In accordance with good modelling practices, all future costs and disability weights were discounted at 3% per year (WHO, 2011b).
Sensitivity analyses
One-way sensitivity analyses were conducted to inform the robustness of the model results to changes in individual parameters. In addition, a probabilistic sensitivity analysis was conducted, in which model parameters were randomly drawn from a pre-specified distribution to generate the incremental cost-effectiveness ratio (ICER). This process was repeated 10 000 times, thereby creating a probabilistic ICER distribution. The upper and lower bounds of our model inputs as well as the corresponding distributional assumptions are displayed in Table 4.
Table 4.
Model inputs
| Mean | Lower limit | Upper limit | Distribution | Reference | |
|---|---|---|---|---|---|
| Age at baseline, in years | 20 | 16 | 24 | Normal | 10 |
| Probability of recto-vaginal fistula | 0.212 | 0.143 | 0.304 | Beta | 18 |
| Probability of vesico-vaginal fistula | 0.788 | 0.696 | 0.857 | N/A | 18 |
| Disability weight, recto-vaginal fistula | 0.492 | 0.328 | 0.667 | Beta | 19 |
| Disability weight, vesico-vaginal fistula | 0.338 | 0.232 | 0.462 | Beta | 19 |
| Disability weight, stress incontinence | 0.142 | 0.089 | 0.209 | Beta | 19 |
| Cost of surgery, in USD | 378.04 | 339.16 | 418.65 | Normal | Own analysis |
| Probability of surgical success | 0.846 | 0.778 | 0.899 | N/A | 18 |
| Probability of surgical failure | 0.063 | 0.044 | 0.083 | Beta | 18 |
| Probability of persistent incontinence | 0.091 | 0.057 | 0.139 | Beta | 18 |
| Discount rate | 0.03 | 0.00 | 0.06 | Beta | 21 |
N/A, Not applicable.
Cost inputs for fistula surgery
In order to obtain the total costs of the Fistula repair the costs of the personnel and laboratory investigations (Table 1A), anaesthesia supplies and equipment (Table 1B), and surgery supplies and equipment (Table 1C) The total cost per surgery on combining all the cost estimations, including 28 day admission costs for the patient was 382.84 USD.
Results
The costs of healthcare resources required for fistula repair are summarized in Tables 1–3. The average cost of fistula repair is estimated at $378.04. The results of our cost-effectiveness analysis are displayed in Table 5. Since 20 is the average age of fistula occurrence among Ugandan women (Barageine et al., 2014; 2015) over the course of her life with fistula in the absence of surgery, the model estimates that she would accrue approximately 8.53 DALYs. According to our model, fistula surgery would reduce that disability burden from 8.53 DALYs to 1.51 DALYs. Fistula surgery does not completely eliminate the DALY burden, because surgery is associated with some probability of surgical failure as well as persistent stress incontinence. Nevertheless, surgery is expected to reduce the disability burden by 7.02 DALYs at a cost of $378.04, yielding an ICER of $54. From our model, surgery costs of up to $4500 would still be cost-effective in this setting.
Table 5.
Base case model results
| Fistula repair surgery | No fistula repair surgery | Difference | |
|---|---|---|---|
| Cost per patient | $378.04 | $0 | $378.04 |
| Lifetime DALYs per patient | 1.51 | 8.53 | 7.02 |
| Cost per DALY averted | $54 |
Results from our one-way sensitivity analysis are displayed in the tornado diagram in Figure 2, which indicates that the results are robust even with major variations in model inputs. The model is most sensitive to variation of the discount rate and the disability weight associated with vesico-vaginal fistula. However, even when varying these two most sensitive parameters, the cost per DALY averted still falls well below relevant cost-effectiveness thresholds. Furthermore, probabilistic sensitivity analysis suggests that 95% of model iterations fell within an ICER range of $40–$79, and 100% of the iterations fall below the per capita GDP threshold in Uganda of approximately $620 (see Figure 3).
Figure 2.
Tornado diagram. Expected Value (EV) of $54 on the x-axis represents the base case cost per DALY averted. The width of the horizontal bars represents how much the base case estimate varies when a single model parameter is replaced with a low and then a high value from a predetermined range. For example, replacing the base case discount of 3% with a low value of 0% reduces the cost per DALY averted from $54 to $28, whereby increasing the same parameter to 6% increases the cost per DALY averted to $84.
Figure 3.

Cost-effectiveness acceptability curve. Willingness to pay refers to the threshold cost per DALY averted at which an intervention is commonly considered to be cost-effective. In this particular case, the threshold is one time per capita GDP in Uganda, e.g. $620. At this threshold, the model results suggest a 100% certainty that OF surgery is cost-effective.
Discussion
Our model’s results suggest that surgery reduces the disability due to obstetric fistula at a cost of $54 per DALY averted, an estimate that falls well below the per capita GDP of $620 in Uganda, indicating that fistula repair is highly cost-effective as per WHO cost-effectiveness thresholds (WHO, 2011b). Our finding is an extension of a previously published analysis that estimated the DALY burden of surgically avertable obstetric conditions in lower- and middle-income countries (Higashi et al., 2015). We build on this research to show that the obstetric fistula public health burden is not merely avertable, but avertable at a reasonable economic cost. While our finding is limited to the Ugandan setting, it seems likely that it would be broadly applicable to other countries in Africa with a similar economic profile and fistula disease burden.
Notably, Uganda and other low-income countries face competing priorities for their health budget, infectious diseases and non-communicable diseases competing with the provision of maternal and child health services necessary to prevent and treat obstetric fistula. In Uganda, broad health system investments for maternal care have been shown to reduce adverse birth outcomes and increase caesarean section rates by up to 31% (Saving mothers giving life organisation, 2018). Such programmes could contribute to prevention of obstetric fistula, by providing the comprehensive obstetric care package with timely interventions thus reducing incidences of neglected prolonged obstructed labour. However when obstetric fistula does occur, surgical repair should be provided because of the severe socioeconomic impacts on the women affected. Furthermore, investments in improved gynaecologic surgical care for obstetric fistula will likely benefit other surgical conditions affecting women of reproductive age.
In this study, we assumed that each surgical team would perform 24 surgeries per month or 288 surgeries per year. For 200 000 untreated women, approximately 70 surgical teams will be needed to conduct surgeries for 10 years to cover these women. Currently, 2 specialized centres in Uganda conduct most of these surgeries, assuming 10 teams between these two centres, another 60 surgical teams will need to be established country wide to support scale up for these surgeries. One policy option could be to expand fistula repair surgery to Uganda’s 14 regional referral hospitals, where theatre infrastructure is already in place and hire and train surgical teams stationed at regional referral hospitals to implement this approach. While scaling up to cover all untreated women may be daunting, expanding high quality fistula care in line with existing plans for regional referral hospitals with two teams in each of the 14 hospitals, would cost approximately $500 000 in salary costs per annum and could reach nearly 50% of affected women over the next decade while also strengthening surgical services for maternal health more broadly. While these estimates exclude other costs eg. Training and other hospitalization costs, it does suggest that fistula surgery may still be affordable given that Uganda is proposing an annual budget of 758 billion Uganda shillings (approximately $217 million) for the FY2018/2019 (Uganda Health Sector Budget framework paper, 2018).
To our knowledge, this is the first publication in the region in which the cost and cost-effectiveness of surgical repair for obstetric fistula were estimated. Sub-Saharan Africa is estimated to have the highest proportion of DALYs due to surgical conditions at 38 per 1000 population (Jamison et al., 2006). This figure includes injuries, malignancies, congenital anomalies, obstetric complications, cataracts and glaucoma and perinatal conditions. Despite the increasing awareness of the importance of strengthening surgical capacity globally, as reflected in the World Bank’s inclusion of surgery in the Disease Control Priorities (Jamison et al., 2006), basic surgical care is not a funding priority in many national policies (Farmer and Kim, 2008). However, to achieve the 2030 objective of sustainable development worldwide, significant advances are required in maternal health—both to treat all obstetric fistula patients and to prevent the emergence of new cases. This will entail a global strategy that includes the strengthening of the health systems and surgical workforce to provide this cost-effective fistula surgery, and address the gaps leading to prolonged obstructed labour in low- and middle-income countries.
In addition to the limited availability of facilities that offer fistula repair and the financial costs of the procedure, a 2017 review highlighted other barriers to fistula treatment occurring at individual, community and national levels These include depression, stigma and shame, lack of community-based referral mechanisms, transportation difficulties, gender power imbalances, community reintegration and the competing priorities of political leadership (Bellows et al., 2015). While these other barriers were not addressed in the model, we feel that critical priorities for early investment should be in health system strengthening because the relative contributions of the other barriers can only be assessed after facilities and resources to conduct surgical repairs are enhanced.
The Lancet commission on surgery reports that 5 billion people worldwide lack access to essential surgery when needed. To address this gap, they recommend scaling up the workforce to 20 surgeons, obstetricians and anaesthetists per 100 000 population by 2030 (Meara et al., 2015). This is much higher than the total number of doctors in many low-income countries. While we believe that a grand convergence in maternal and neonatal health is possible by 2030, sustainable solutions for low- and middle-income countries will involve increased investments in health care and support for the training of more medical doctors. From our model, increasing the salaries for the surgical workforce would still be highly cost-effective and would attract more clinicians to participate in this noble service. Our recommendations are in line with the World Bank’s third edition of Disease Control Priorities, which highlights surgical procedures as cost-effective health care interventions and advocates for their inclusion in promoting universal health coverage (Mock et al., 2015).
Limitations
This cost-effective analysis considered the costs of fistula repair at the Mulago and Kitovu Referral Hospital. These hospitals were purposefully selected as they conduct the highest numbers of fistula repairs in the country, but it is not known whether the costs in these settings can be generalized to other healthcare settings in Uganda or other countries in Sub-Saharan Africa with comparable healthcare systems. In addition, this study did not include the capital costs associated with the hospital building or land in the micro-costing methodology, as historical cost records were unavailable. Furthermore, the outcomes associated with fistula repair surgery were based on a published study of patients at Addis Ababa Fistula Hospital in Ethiopia, where patients may have experienced outcomes that differed from those experienced by patients in Uganda. Lastly, the modelling was based on the 2 weeks’ post-surgery hospital stay and 3 hours’ duration of operation per repair. This may not be the case in some uncomplicated fistulas, which may take <3 h, and more complex ones, which would require >2 weeks post-surgery stay in the hospital. However, during the sensitivity analyses, the results were non-differential upon consideration of time for surgery.
Conclusions
Surgery for obstetric fistula repair appears highly cost-effective in Uganda, suggesting that this intervention constitutes an efficient use of scarce healthcare resources and that a broader use of this intervention would be economically justified. There is need for government, policy-makers and all partners to increase access to surgical care through prioritizing surgical training, increasing salaries and strengthening the infrastructure across the country, which would be an important step towards achieving universal health coverage.
Prevention of obstetric complications could also heighten the cost-effectiveness and feasibility of obstetric fistula surgical repair. We recommend task-sharing to increase capacity for timely caesarean sections by providing training for doctors and midwives to perform emergency caesarean sections and provide safe anaesthesia, thus increasing access to essential surgery in the community. Given that an estimated 15–20% of all pregnancies worldwide require surgical intervention, task-sharing would reduce maternal mortality and morbidity, thereby lowering the costs to society of averting related complications such as obstetric fistula.
Acknowledgements
We are grateful for the support from UCGHI Center for Expertise in Women and SONKE Gender Justice Seed grant towards this cost analysis.
Conflict of interest statement. None declared.
Ethics approval
The School of Medicine Research Ethics Committee Makerere University College of Health Sciences Research and Ethics Committee (SOMREC), REC REF No. 2014-133, approved this study.
Funding
This study was sponsored by the USA National Institutes of Health; (NIH Research Training Grant Number #R25TW009343) during the corresponding author's 2014/2015 Post-doctoral Fellowship in Global Health with UCGHI.
References
- Adler A, Ronsmans C, Calvert C, Filippi V.. 2013. Estimating the prevalence of obstetric fistula: a systematic review and meta-analysis. BMC Pregnancy and Childbirth 13: 246.. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Ahmed S, Genadry R, Stanton C, Lalonde AB.. 2007. Dead women walking: neglected millions with obstetric fistula. <i>International Journal of Gynecology & Obstetrics</i> 99(Suppl 1): S1–S3. [DOI] [PubMed] [Google Scholar]
- Arrowsmith SD, Ruminjo J, Landry EG.. 2010. Current practices in treatment of female genital fistula: a cross sectional study. BMC Pregnancy and Childbirth 10: 73.. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Barageine JK, Beyeza-Kashesya J, Byamugisha JK. et al. 2015. “I am alone and isolated”: a qualitative study of experiences of women living with genital fistula in Uganda. BMC Womens Health 15: 73. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Barageine JK, Tumwesigye NM, Byamugisha JK, Almroth L, Faxelid E.. 2014. Risk factors for obstetric fistula in Western Uganda: a case control study. PLoS One 9: e112299.. 10.1371/journal.pone.0112299. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Bellows B, Bach R, Baker Z, Warren C.. 2015. Barriers to Obstetric Fistula Treatment in Low-Income Countries: A Systematic Review. Nairobi: Population Council, 13–15. [DOI] [PubMed] [Google Scholar]
- Brian H, Browning A.. 2009. A Text Book of Practical Obstetric Fistula Surgery. London: Royal Society of Medicine Press Ltd. [Google Scholar]
- Browning A, Fentahun W, Goh JT.. 2007. The impact of surgical treatment on the mental health of women with obstetric fistula. BJOG 114: 1439–41. [DOI] [PubMed] [Google Scholar]
- Creanga Andrerea A, Zubairu I, Arinaitwe Loyce K.. 2008. An Evaluation of the United Nations Population Fund/Uganda's Obstetric Fistula Program. New York: UNFPA Publication. [Google Scholar]
- Farmer PE, Kim JY.. 2008. Surgery and global health: a view from beyond the OR. World Journal of Surgery 32: 533–6. [DOI] [PMC free article] [PubMed] [Google Scholar]
- International Federation of Gynecology and Obstetrics (FIGO) , International Society of Obstetric Fistula Surgeons (ISOFS), United Nations Population Fund (UNFPA) and EngenderHealth Royal College of Obstetricians and Gynaecologists (RCOG). 2011. Global Competency-Based Fistula Surgery Training Manual. London: FIGO; https://www.figo.org/sites/default/files/uploads/wg-publications/fistula/FIGO_Global_Competency-Based_Fistula_Surgery_Training_Manual_0.pdf, accessed September 2018. [Google Scholar]
- Hancock B. 2005. First steps in vesico-vaginal fistula repair. Tropical Doctor 35: 1–59.15712527 [Google Scholar]
- Hancock B. 2009. Practical Obstetric Fistula Surgery. London: Royal Society of Medicine Press, pp. 167. [Google Scholar]
- Hendriks ME, Kundu P, Boers AC. et al. 2014. Step-by-step guideline for disease-specific costing studies in low-and middle-income countries: a mixed methodology. Global Health Action 7: 23573.. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Higashi H, Barendregt JJ, Kassebaum NJ. et al. 2015. Surgically avertable burden of obstetric conditions in low- and middle-income regions: a modelled analysis. BJOG: An International Journal of Obstetrics & Gynaecology 122: 228–36. [DOI] [PubMed] [Google Scholar]
- Hilton P, Ward A.. 1998. Epidemiological and surgical aspects of urogenital fistulae: a review of 25 years’ experience in southeast Nigeria. International Urogynecology Journal 9: 189–94. [DOI] [PubMed] [Google Scholar]
- Holme A, Breen M, MacArthur C.. 2007. Obstetric fistulae: a study of women managed at the Monze Mission Hospital, Zambia. BJOG: An International Journal of Obstetrics & Gynaecology 114: 1010–7. [DOI] [PubMed] [Google Scholar]
- Jamison DT, Breman JG, Measham AR. et al. 2006. Disease Control Priorities in Developing Countries, 2nd ed. Washington, DC: The World Bank/Oxfprd University Press. [PubMed] [Google Scholar]
- JMS Uganda. 2016. Joint Medical Stores Catalogue and Price Indicator. Kampala, Uganda: Joint Medical Stores. [Google Scholar]
- Kayondo M, Wasswa S, Kabakyenga J. et al. 2011. Predictors and outcome of surgical repair of obstetric fistula at a regional referral hospital, Mbarara, western Uganda. BMC Urology 11: 23.. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Kelly J. 1992. Vesico-vaginal and recto-vaginal fistulae. Journal of the Royal Society of Medicine 85: 257–8. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Kelly J, Winter HR.. 2007. Reflections on the knowledge base for obstetric fistula. International Journal of Gynecology & Obstetrics 99: S21–S4. [DOI] [PubMed] [Google Scholar]
- Lewis G, de Bernis L.. World Health Organization. 2006. Obstetric fistula: guiding principles for clinical management and programme development. Geneva: World Health Organization; http://www.who.int/iris/handle/10665/43343, accessed September 2018. [Google Scholar]
- Lozano R, Naghavi M, Foreman K. et al. 2012. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. The Lancet 380: 2095–128. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Meara JG, Leather AJM, Hagander L. et al. 2015. Global Surgery 2030: evidence and solutions for achieving health, welfare, and economic development. The Lancet 158: 3–624. [DOI] [PubMed] [Google Scholar]
- Mock CN, Donkor P, Gawande A. et al. 2015. Essential surgery: key messages from Disease Control Priorities. The Lancet 385: 2209–19. [DOI] [PMC free article] [PubMed] [Google Scholar]
- MOH. 2007. Roadmap for Accelerating the Reduction of Maternal and Neonatal Mortalityand Morbidity in Uganda. Kampala, Uganda: Ministry of Health. [Google Scholar]
- MOH. 2011. Uganda National Obstetric Fistula Strategy 2011–2016. Kampla, Uganda: MOH. [Google Scholar]
- Mselle LT, Kohi TW.. 2015. Living with constant leaking of urine and odour: thematic analysis of socio-cultural experiences of women affected by obstetric fistula in rural Tanzania. BMC Women's Health 15: 107.. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Raassen TJIP, Verdaasdonk EGG, Vierhout ME.. 2008. Prospective results after first-time surgery for obstetric fistulas in East African women. International Urogynecology Journal 19: 73–9. [DOI] [PubMed] [Google Scholar]
- Salomon JA, Vos T, Hogan DR. et al. 2012. Common values in assessing health outcomes from disease and injury: disability weights measurement study for the Global Burden of Disease Study 2010. The Lancet 380: 2129–43. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Saving mothers giving life organisation. 2018. Saving Mothers Giving Life [Online]. Kampala, Uganda. http://www.savingmothersgivinglife.org/our-work/uganda.aspx, accessed 22 June 2018.
- Tebeu PM, Fomulu JN, Khaddaj S. et al. 2012. Risk factors for obstetric fistula: a clinical review. International Urogynecology Journal 23: 387–94. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Uganda Bureau of Statistics (UBOS) and ICF International Inc. 2012. Uganda Demographic and Health Survey 2011. Kampala, Uganda: UBOS and Calverton, Maryland: ICF International Inc. [Google Scholar]
- Uganda Health Sector Budget framework paper. 2018. http://ugandajournalistsresourcecentre.com/uganda-health-sector-budget-framework-paper-fy-201819-fy-202223/
- UNFPA. 2005. The Campaign to End Fistula. Annual Report.
- UNFPA, EngenderHealth and MOH. 2003. Obstetric Fistula Needs Assessment Report:Findings from nine African countries. New York, USA: United Nations Population Fund, pp. 98. https://www.unfpa.org/publications/obstetric-fistula-needs-assessment, accessed September 2018. [Google Scholar]
- Vangeenderhuysen C, Prual A, Ould el Joud D.. 2001. Obstetric fistulae: incidence estimates for Sub-Saharan Africa. International Journal of Gynecology & Obstetrics 73: 65–6. [DOI] [PubMed] [Google Scholar]
- Waaldijk K. 1995. Surgical classification of obstetric fistulas. International Journal of Gynecology & Obstetrics 49: 161–3. [DOI] [PubMed] [Google Scholar]
- Waaldijk K. 2004. The immediate management of fresh obstetric fistulas. American Journal of Obstetrics & Gynecology 191: 795–9. [DOI] [PubMed] [Google Scholar]
- Wall LL. 2006. Obstetric vesicovaginal fistula as an international public-health problem. The Lancet 368: 1201–9. [DOI] [PubMed] [Google Scholar]
- WHO. 2011a. Global Health Observatory Geneva, Switzerland: World Health Organization. [Google Scholar]
- WHO. 2011b. World Health Organization. Cost-Effectiveness Thresholds. Choosing Interventions That are Cost Effective (WHO-CHOICE). Geneva, Switzerland: World Health Organization. [Google Scholar]
- World Health Organization. 2015. Trends in maternal mortality: 1990–2015: estimates from WHO, UNICEF, UNFPA, World Bank Group and the United Nations Population Division: executive summary.
- You D, Hug L, Ejdemyr S. et al. 2015. Global, regional, and national levels and trends in under-5 mortality between 1990 and 2015, with scenario-based projections to 2030: a systematic analysis by the UN Inter-agency Group for Child Mortality Estimation. The Lancet 386: 2275–86. [DOI] [PubMed] [Google Scholar]


